Chemo may extend survival after breast cancer's return
(HealthDay)—In women with breast cancer that has recurred but remains confined to in or near the breast, post-surgical chemotherapy appears to boost survival, new research shows.
Dec 6, 2012
Archive: 06/12/2012
Agreement boosts access for American Indian vets
(AP)—Native American military veterans will be able to access health care closer to home thanks to an agreement between the U.S. Department of Veteran Affairs and the Indian Health Service.
Dec 6, 2012
For aggressive breast cancer, chemo may work better in the young
(HealthDay)—Younger women with aggressive breast cancers often benefit more than older women when they undergo early, pre-operative chemotherapy, a new study finds.
Dec 6, 2012
Health warning on new round of fungal infections
(AP)—Tennessee health officials are once again alerting patients who received tainted steroid shots after finding that some have infections at the injection site that could lead to fungal meningitis.
Dec 6, 2012
Women with higher carotenoid levels have reduced risk of breast cancer
Women with higher circulating carotenoid levels are at a reduced risk of breast cancer according to a study published December 6 in the Journal of the National Cancer Institute
Dec 6, 2012
Evidence supports premise: OR distractions up surgical errors
(HealthDay)—Typical operating room distractions and interruptions (ORDIs) potentially increase the likelihood of surgical errors among surgical trainees, according to a study published in the November issue of the Archives ...
Dec 6, 2012
General thoracic surgeons emerge as leading providers of complex, noncardiac thoracic surgery
While thoracic surgeons are traditionally known as the experts who perform heart surgeries, a UC Davis study has found that general thoracic surgeons, especially those at academic health centers, perform the vast majority ...
Dec 6, 2012
TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) ...
Dec 6, 2012
